We’re happy and proud to announce that Basepaws, a phenomenal pet care genetics startup that develops early detection health risk tests based on generic and microbiome data and a portfolio company of Intango Ventures, has been acquired by Zoetis, Inc. (NYSE:ZTS), the world’s leading animal health company!
We invested in Basepaws in 2020 prior to the global pandemic of COVID-19, when home testing kits weren’t widely accepted practices. During the past two years, we witnessed the fast growth of the company with a very visionary strategy led by Anna Skaya, the CEO of Basepaws, utilizing the power of direct-to-customer eCommerce channels to bring the products of Basepaws to the targeted online consumers with extremely high intent and great care for the health of their pets.
We would like to deliver a big congratulations to Anna and her exceptional team for bringing the company to such an incredible achievement. As an early-stage venture investor, Intango Ventures is very proud to see the successful exit of Basepaws, together with our venture partner Plug and Play.
We wish the Basepaws team great success in their new home and future endeavors.